Literature DB >> 10786796

CD1c-mediated T-cell recognition of isoprenoid glycolipids in Mycobacterium tuberculosis infection.

D B Moody1, T Ulrichs, W Mühlecker, D C Young, S S Gurcha, E Grant, J P Rosat, M B Brenner, C E Costello, G S Besra, S A Porcelli.   

Abstract

The discovery of the CD1 antigen presentation pathway has expanded the spectrum of T-cell antigens to include lipids, but the range of natural lipid antigens and functions of CD1-restricted T cells in vivo remain poorly understood. Here we show that the T-cell antigen receptor and the CD1c protein mediate recognition of an evolutionarily conserved family of isoprenoid glycolipids whose members include essential components of protein glycosylation and cell-wall synthesis pathways. A CD1c-restricted, mycobacteria-specific T-cell line recognized two previously unknown mycobacterial hexosyl-1-phosphoisoprenoids and structurally related mannosyl-beta1-phosphodolichols. Responses to mannosyl-beta1-phosphodolichols were common among CD1c-restricted T-cell lines and peripheral blood T lymphocytes of human subjects recently infected with M. tuberculosis, but were not seen in naive control subjects. These results define a new class of broadly distributed lipid antigens presented by the CD1 system during infection in vivo and suggest an immune mechanism for recognition of senescent or transformed cells that are known to have altered dolichol lipids.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10786796     DOI: 10.1038/35009119

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  148 in total

1.  Ligand-independent assembly of recombinant human CD1 by using oxidative refolding chromatography.

Authors:  M M Altamirano; A Woolfson; A Donda; A Shamshiev; L Briseño-Roa; N W Foster; D B Veprintsev; G De Libero; A R Fersht; C Milstein
Journal:  Proc Natl Acad Sci U S A       Date:  2001-03-13       Impact factor: 11.205

Review 2.  Right on target: novel approaches for the direct visualization of CD1-specific T cell responses.

Authors:  M Kronenberg; O Naidenko; F Koning
Journal:  Proc Natl Acad Sci U S A       Date:  2001-03-13       Impact factor: 11.205

Review 3.  Antigen recognition by human gamma delta T cells: pattern recognition by the adaptive immune system.

Authors:  C T Morita; R A Mariuzza; M B Brenner
Journal:  Springer Semin Immunopathol       Date:  2000

4.  Regulation of intracellular trafficking of human CD1d by association with MHC class II molecules.

Authors:  Suk-Jo Kang; Peter Cresswell
Journal:  EMBO J       Date:  2002-04-02       Impact factor: 11.598

5.  Intracellular trafficking pathway of newly synthesized CD1b molecules.

Authors:  V Briken; R M Jackman; S Dasgupta; S Hoening; S A Porcelli
Journal:  EMBO J       Date:  2002-02-15       Impact factor: 11.598

Review 6.  A new aspect in glycolipid biology: glycosphingolipids as antigens recognized by T lymphocytes.

Authors:  G De Libero; A Donda; H J Gober; V Manolova; Z Mazorra; A Shamshiev; L Mori
Journal:  Neurochem Res       Date:  2002-08       Impact factor: 3.996

Review 7.  Role of CD1d-restricted NKT cells in microbial immunity.

Authors:  Markus Sköld; Samuel M Behar
Journal:  Infect Immun       Date:  2003-10       Impact factor: 3.441

8.  Inhibition of CD1 expression in human dendritic cells during intracellular infection with Leishmania donovani.

Authors:  Joseph L Amprey; Gerald F Späth; Steven A Porcelli
Journal:  Infect Immun       Date:  2004-01       Impact factor: 3.441

9.  Molecular requirements for T cell recognition of N-myristoylated peptides derived from the simian immunodeficiency virus Nef protein.

Authors:  Daisuke Morita; Yukie Yamamoto; Juri Suzuki; Naoki Mori; Tatsuhiko Igarashi; Masahiko Sugita
Journal:  J Virol       Date:  2012-10-24       Impact factor: 5.103

Review 10.  Lipid presentation by human CD1 molecules and the diverse T cell populations that respond to them.

Authors:  Erin J Adams
Journal:  Curr Opin Immunol       Date:  2013-10-11       Impact factor: 7.486

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.